USPTO serial 99580472
TUFINMO
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- BOONE, JOHN C
- Law office
- TMO LAW OFFICE 302
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TUFINMO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sodertalje, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leonid Rakitin
Leonid Rakitin AstraZeneca Pharmaceuticals LP950 Wind River LaneGaithersburg, MD 20878United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for the treatment of antibodies; Vaccines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 6, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 6, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 20, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 20, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2026 | NWAP | NEW APPLICATION ENTERED | — |